NCT02904902 - Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2016

Primary Completion Date

September 1, 2017

Study Completion Date

May 30, 2019

Conditions

Hidradenitis Suppurativa

Interventions

DRUG

adalimumab

Subcutaneous Injection

Trial Locations (8)

Nagoya City University Hospital /ID# 151495, Nagoya

Kurume University Hospital /ID# 152579, Kurume-shi

Takagi Dermatological Clinic /ID# 151906, Obihiro

University of the Ryukyus Hosp /ID# 152268, Nakagami-gun

NHO Osaka National Hosp /ID# 152452, Osaka

Tokai University Hachioji Hosp /ID# 151338, Hachiōji

Tokyo Medical University Hospital /ID# 154171, Shinjuku-ku

Fukuoka University Hospital /ID# 151350, Fukuoka